These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 16710039

  • 21. Agranulocytosis occurring in a patient with chronic lymphocytic leukemia in complete remission; treatment by rituximab and cyclosporin.
    Costello RT, Sébahoun G.
    Leuk Res; 2010 Dec; 34(12):e329-30. PubMed ID: 20723978
    [No Abstract] [Full Text] [Related]

  • 22. Pure red-cell aplasia requiring cytotoxic chemotherapy: presence of clonal T-lymphocytes without characteristics of chronic lymphocytic leukemia.
    Nezu M, Kawano E, Ishii H, Nishimura M, Hirasawa A, Hashimoto S, Morio S, Aotsuka N, Nakamura H, Asai T, Saito Y, Oh H.
    Am J Hematol; 1996 Oct; 53(2):145-7. PubMed ID: 8892747
    [No Abstract] [Full Text] [Related]

  • 23. [Recent progress in the therapeutic strategy for follicular lymphoma and mantle cell lymphoma].
    Ogura M.
    Rinsho Ketsueki; 2006 Jun; 47(6):495-512. PubMed ID: 16862978
    [No Abstract] [Full Text] [Related]

  • 24. A long-lasting third complete remission after second autologous transplant followed by maintenance treatment with rituximab in a patient with diffuse large cell non-Hodgkin's lymphoma.
    Ataergin S, Arpaci F, Beyzadeoglu M, Safali M, Ozet A.
    Am J Hematol; 2006 Dec; 81(12):986-7. PubMed ID: 16886214
    [No Abstract] [Full Text] [Related]

  • 25. Aggressive lymphoma involving intracranial epidural region.
    Villela LM, Blanco-Salazar A, Caballero R, Borbolla-Escoboza R.
    J Neurooncol; 2007 Jun; 83(2):181-2. PubMed ID: 17332949
    [No Abstract] [Full Text] [Related]

  • 26. Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.
    Grange F, Maubec E, Bagot M, Beylot-Barry M, Joly P, Dalle S, Delaporte E, Dereure O, Bachelez H, Vergier B, Petrella T, D'Incan M.
    Arch Dermatol; 2009 Mar; 145(3):329-30. PubMed ID: 19289772
    [No Abstract] [Full Text] [Related]

  • 27. Primary cardiac non-Hodgkin lymphoma presenting with atrial flutter and pericardial effusion.
    Piccaluga PP, Vigna E, Placci A, Agostinelli C, Laterza C, Papayannidis C, Leone O, Martinelli G, Zinzani PL, Baccarani M, Pileri SA.
    Br J Haematol; 2006 Aug; 134(4):356. PubMed ID: 16882130
    [No Abstract] [Full Text] [Related]

  • 28. Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?
    Ahmadi T, Schuster SJ.
    J Clin Oncol; 2009 Feb 01; 27(4):479-80. PubMed ID: 19075263
    [No Abstract] [Full Text] [Related]

  • 29. Evaluation of morpho/immunological telehaematology file exchanges for the inclusion of patients with chronic lymphocytic leukaemia in a therapeutic trial.
    Lesesve J, Palmiéri A, Brion A, Feugier P, Mahé B, Garand R, Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS).
    Int J Lab Hematol; 2008 Jun 01; 30(3):256-8. PubMed ID: 18479305
    [No Abstract] [Full Text] [Related]

  • 30. Changing the way we think about chronic lymphocytic leukemia.
    Lin TS, Grever MR, Byrd JC.
    J Clin Oncol; 2005 Jun 20; 23(18):4009-12. PubMed ID: 15767640
    [No Abstract] [Full Text] [Related]

  • 31. Blood histamine levels in patients with chronic lymphocytic leukemia.
    Belcheva A.
    Inflamm Res; 1999 Apr 20; 48 Suppl 1():S53-4. PubMed ID: 10350160
    [No Abstract] [Full Text] [Related]

  • 32. Obstructive sleep apnea secondary to chronic lymphocytic leukemia.
    Chehal A, Haidar JH, Jabbour R, Yammout B, Bazarbachi A.
    Ann Oncol; 2002 Nov 20; 13(11):1833. PubMed ID: 12419760
    [No Abstract] [Full Text] [Related]

  • 33. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial.
    Ribera JM, Oriol A, Morgades M, González-Barca E, Miralles P, López-Guillermo A, Gardella S, López A, Abella E, García M, PETHEMA, GELTAMO, GELCAB and GESIDA Groups.
    Br J Haematol; 2008 Feb 20; 140(4):411-9. PubMed ID: 18162120
    [Abstract] [Full Text] [Related]

  • 34. Splenic marginal zone lymphoma: transformation to diffuse large B-cell lymphoma with isolated cerebral manifestation.
    Thoennissen NH, Keyvani K, Voelker HU, Bremer J, Krug U, Müller-Tidow C, Koch P, Müller-Hermelink HK, Berdel WE.
    J Clin Oncol; 2008 Sep 20; 26(27):4509-11. PubMed ID: 18802164
    [No Abstract] [Full Text] [Related]

  • 35. Pericardial involvement in a non-Hodgkin lymphoma patient: coregistered FDG-PET and CT imaging.
    Weijs LE, Arsos G, Baarslag HJ, Wittebol S, de Klerk JM.
    Eur Heart J; 2007 Nov 20; 28(22):2698. PubMed ID: 17567624
    [No Abstract] [Full Text] [Related]

  • 36. Paraneoplastic pemphigus associated with chronic lymphocytic leukaemia: treatment with alemtuzumab.
    Ekbäck M, Uggla B.
    Leuk Res; 2012 Aug 20; 36(8):e190-1. PubMed ID: 22579369
    [No Abstract] [Full Text] [Related]

  • 37. Bendamustine in chronic lymphocytic leukemia and refractory lymphoma.
    Rummel MJ.
    Semin Hematol; 2008 Jul 20; 45(3 Suppl 2):S7-10. PubMed ID: 18760709
    [Abstract] [Full Text] [Related]

  • 38. [Recent therapeutic progress in non-Hodgkin lymphoma: focusing on diffuse large B-cell lymphoma and follicular lymphoma].
    Ogura M.
    Rinsho Ketsueki; 2008 Oct 20; 49(10):1434-50. PubMed ID: 18833928
    [No Abstract] [Full Text] [Related]

  • 39. Direct antiglobulin test negative autoimmune haemolytic anaemia associated with fludarabine/cyclophosphamide/rituximab therapy.
    Garratty G, Petz LD.
    Br J Haematol; 2007 Nov 20; 139(4):622-3. PubMed ID: 17979948
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.